Modulus Systems LLC v. Moko Technology Co., Ltd

Court

District Court, E.D. Texas (E.D. Tex.)
Official Court Website →

Assigned judge

Rodney Gilstrap · 8,688 cases in index

Docket number

2:23-cv-00241

Cause

35:271 Patent Infringement
35 U.S.C. § 271 — Patent infringement

Nature of suit

835 Patent - Abbreviated New Drug Application(ANDA)
Hatch-Waxman patent disputes over a generic-drug (ANDA) application.

Jurisdiction

Federal Question

Jury demand

Plaintiff

Date filed

05/27/2023

4 Patent - ANDA cases in this court are indexed here.

Parties

• plaintiff · Modulus Systems LLC · 8 cases
• defendant · Moko Technology Co., Ltd

Part of a Larger Litigation Pattern

This is one of 2 Patent - ANDA cases in our index naming MOKO Technology Co., Ltd — a possible mass-tort or coordinated-litigation cluster.

About Patent - ANDA Lawsuits

ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

Frequently Asked Questions

What is Modulus Systems LLC v. Moko Technology Co., Ltd?

Modulus Systems LLC v. Moko Technology Co., Ltd is a federal patent - anda lawsuit filed on 05/27/2023 in the District Court, E.D. Texas. The case is currently open in the federal court system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What type of case is this?

It is classified as “Patent - ANDA” under the federal nature-of-suit system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What court is the case in?

The case is in the District Court, E.D. Texas, docket number 2:23-cv-00241.

When was the case filed?

Modulus Systems LLC v. Moko Technology Co., Ltd was filed on 05/27/2023. The case is currently open.

What law is the case brought under?

The docket lists the cause as 35 U.S.C. § 271 — Patent infringement.